Beech Hill Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,050
Closed -$242K 88
2016
Q3
$242K Buy
+1,050
New +$257K 0.15% 73
2016
Q2
Sell
-2,217
Closed -$594K 81
2016
Q1
$594K Sell
2,217
-498
-18% -$143K 0.46% 34
2015
Q4
$848K Buy
2,715
+975
+56% +$290K 0.54% 40
2015
Q3
$473K Sell
1,740
-1,012
-37% -$311K 0.3% 58
2015
Q2
$835K Sell
2,752
-208
-7% -$62K 0.43% 45
2015
Q1
$881K Sell
2,960
-180
-6% -$51.3K 0.41% 44
2014
Q4
$808K Buy
3,140
+377
+14% +$94.2K 0.4% 42
2014
Q3
$667K Buy
2,763
+45
+2% +$10.1K 0.32% 61
2014
Q2
$606K Buy
+2,718
New +$563K 0.27% 72

Other funds holding AGN

Beech Hill Advisors's AGN Position: Q4 2016 in Review

Beech Hill Advisors sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 1,050 shares — an estimated $242K sold.

Beech Hill Advisors first reported a position in AGN in Q2 2014 and held it in 9 quarters. The position peaked at $881K in Q1 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Beech Hill Advisors reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Beech Hill Advisors sold 1,050 Allergan plc shares in Q4 2016, an estimated $242K.
  • Beech Hill Advisors first reported a position in Allergan plc in Q2 2014 and held it in 9 quarters.
  • Beech Hill Advisors's Allergan plc position peaked at $881K in Q1 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Beech Hill Advisors's 13F filing for Q4 2016, filed 26 Jan 2017.